Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor

BACKGROUND: Sarcopenia is a progressive generalized loss of skeletal muscle mass commonly observed in advanced stages of cancer. OBJECTIVE: To assess the relationship between sarcopenia and the prognosis of patients with hepatocellular carcinoma (HCC) treated with a programmed cell death 1 (PD-1) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yusheng, Ren, Yanqiao, Wu, Feihong, Dong, Xiangjun, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806410/
https://www.ncbi.nlm.nih.gov/pubmed/36600683
http://dx.doi.org/10.1177/17562848221142417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806410/
https://www.ncbi.nlm.nih.gov/pubmed/36600683
http://dx.doi.org/10.1177/17562848221142417

Ejemplares similares